Published in Free Radic Res on July 01, 2003
Antioxidants as therapeutic agents for liver disease. Liver Int (2011) 1.02
The use of selected nutrition supplements and complementary and alternative medicine in liver disease. Nutr Clin Pract (2006) 0.89
Coinfection with hepatitis C virus, oxidative stress and antioxidant status in HIV-positive drug users in Miami. HIV Med (2011) 0.87
Treatment of nonalcoholic steatohepatitis with vitamins E and C: a pilot study. Hepat Med (2013) 0.85
Hepatitis C virus to hepatocellular carcinoma. Infect Agent Cancer (2012) 0.82
Nutritional therapy and infectious diseases: a two-edged sword. Nutr J (2006) 0.79
Acrolein, a ubiquitous pollutant and lipid hydroperoxide product, inhibits antiviral activity of interferon-alpha: relevance to hepatitis C. Free Radic Biol Med (2009) 0.79
An analysis of risk factors for developing Hepatocellular carcinoma in a group of Hepatitis C patients with stage 3 fibrosis following interferon therapy. Cancer Inform (2008) 0.77
Prevention of hepatocellular carcinoma: Focusing on antioxidant therapy. World J Hepatol (2015) 0.75
Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes. Nat Immunol (2010) 6.64
Redox control of cell death. Antioxid Redox Signal (2002) 2.08
Thioredoxin-2 (TRX-2) is an essential gene regulating mitochondria-dependent apoptosis. EMBO J (2002) 1.82
Cardioprotective effects of thioredoxin in myocardial ischemia and reperfusion: role of S-nitrosation [corrected]. Proc Natl Acad Sci U S A (2004) 1.76
Myocardial bundles with slow conduction properties are present on the left interventricular septal surface of normal human hearts. J Cardiovasc Electrophysiol (2004) 1.75
Redox-active protein thioredoxin prevents proinflammatory cytokine- or bleomycin-induced lung injury. Am J Respir Crit Care Med (2003) 1.74
Nitric oxide induces hypoxia-inducible factor 1 activation that is dependent on MAPK and phosphatidylinositol 3-kinase signaling. J Biol Chem (2003) 1.57
Genetic polymorphisms of the human PNPLA3 gene are strongly associated with severity of non-alcoholic fatty liver disease in Japanese. PLoS One (2012) 1.56
Characteristics of patients with nonalcoholic steatohepatitis who develop hepatocellular carcinoma. Clin Gastroenterol Hepatol (2011) 1.56
Thioredoxin and thioredoxin-binding protein-2 in cancer and metabolic syndrome. Free Radic Biol Med (2007) 1.56
Peri-infarct depolarizations lead to loss of perfusion in ischaemic gyrencephalic cerebral cortex. Brain (2007) 1.56
Thioredoxin-1 ameliorates myosin-induced autoimmune myocarditis by suppressing chemokine expressions and leukocyte chemotaxis in mice. Circulation (2004) 1.55
Persisting depletion of brain glucose following cortical spreading depression, despite apparent hyperaemia: evidence for risk of an adverse effect of Leão's spreading depression. J Cereb Blood Flow Metab (2008) 1.55
Thioredoxin in human and experimental sepsis. Crit Care Med (2009) 1.51
Thioredoxin: friend or foe in human disease? Trends Pharmacol Sci (2005) 1.50
Glutaredoxin exerts an antiapoptotic effect by regulating the redox state of Akt. J Biol Chem (2003) 1.49
A receiver diversity technique for ensuring high reliability of wireless vital data gathering in hospital rooms. Conf Proc IEEE Eng Med Biol Soc (2010) 1.47
Coronary sinus recordings of double potentials associated with retrograde conduction through left atrioventricular accessory pathways. J Cardiovasc Electrophysiol (2004) 1.47
Thioredoxin as a molecular target of cyclopentenone prostaglandins. J Biol Chem (2003) 1.45
Redox-sensitive cysteines bridge p300/CBP-mediated acetylation and FoxO4 activity. Nat Chem Biol (2009) 1.40
A comparative study on the hydroperoxide and thiol specificity of the glutathione peroxidase family and selenoprotein P. J Biol Chem (2002) 1.39
Thioredoxin binding protein-2/thioredoxin-interacting protein is a critical regulator of insulin secretion and peroxisome proliferator-activated receptor function. Endocrinology (2008) 1.30
Current status of chromosomal abnormalities in mouse embryonic stem cell lines used in Japan. Comp Med (2006) 1.29
Impaired fatty acid utilization in thioredoxin binding protein-2 (TBP-2)-deficient mice: a unique animal model of Reye syndrome. FASEB J (2005) 1.29
Overexpression of human thioredoxin in transgenic mice controls oxidative stress and life span. Antioxid Redox Signal (2002) 1.29
High thioredoxin expression is associated with resistance to docetaxel in primary breast cancer. Clin Cancer Res (2005) 1.28
The involvement of thioredoxin and thioredoxin binding protein-2 on cellular proliferation and aging process. Ann N Y Acad Sci (2005) 1.28
Overexpression of thioredoxin-1 in transgenic mice attenuates adriamycin-induced cardiotoxicity. Circulation (2002) 1.26
Loss of thioredoxin-binding protein-2/vitamin D3 up-regulated protein 1 in human T-cell leukemia virus type I-dependent T-cell transformation: implications for adult T-cell leukemia leukemogenesis. Cancer Res (2004) 1.25
Importin alpha1 (Rch1) mediates nuclear translocation of thioredoxin-binding protein-2/vitamin D(3)-up-regulated protein 1. J Biol Chem (2004) 1.24
17Beta-estradiol protects against oxidative stress-induced cell death through the glutathione/glutaredoxin-dependent redox regulation of Akt in myocardiac H9c2 cells. J Biol Chem (2006) 1.20
Thioredoxin reductase regulates AP-1 activity as well as thioredoxin nuclear localization via active cysteines in response to ionizing radiation. Oncogene (2002) 1.18
Thioredoxin-binding protein-2-like inducible membrane protein is a novel vitamin D3 and peroxisome proliferator-activated receptor (PPAR)gamma ligand target protein that regulates PPARgamma signaling. Endocrinology (2005) 1.17
Serum thioredoxin levels as a predictor of steatohepatitis in patients with nonalcoholic fatty liver disease. J Hepatol (2003) 1.17
Thioredoxin-dependent redox regulation of the antioxidant responsive element (ARE) in electrophile response. Oncogene (2003) 1.16
Thioredoxin prevents the development and progression of elastase-induced emphysema. Biochem Biophys Res Commun (2007) 1.16
Anti-oxidative, anti-cancer and anti-inflammatory actions by thioredoxin 1 and thioredoxin-binding protein-2. Pharmacol Ther (2010) 1.15
Sulforaphane induces thioredoxin through the antioxidant-responsive element and attenuates retinal light damage in mice. Invest Ophthalmol Vis Sci (2005) 1.15
Disruption of TBP-2 ameliorates insulin sensitivity and secretion without affecting obesity. Nat Commun (2010) 1.13
An endogenous electrophile that modulates the regulatory mechanism of protein turnover: inhibitory effects of 15-deoxy-Delta 12,14-prostaglandin J2 on proteasome. Biochemistry (2003) 1.13
Change of redox status and modulation by thiol replenishment in retinal photooxidative damage. Invest Ophthalmol Vis Sci (2002) 1.12
Human thioredoxin-1 ameliorates experimental murine colitis in association with suppressed macrophage inhibitory factor production. Gastroenterology (2006) 1.11
Risk factors for cyclosporine-induced tubulointerstitial lesions in children with minimal change nephrotic syndrome. Kidney Int (2002) 1.10
Two distinct mechanisms for loss of thioredoxin-binding protein-2 in oxidative stress-induced renal carcinogenesis. Lab Invest (2005) 1.10
Thioredoxin as a biomarker for oxidative stress in patients with rheumatoid arthritis. Mol Immunol (2002) 1.10
Thioredoxin as a key molecule in redox signaling. Antioxid Redox Signal (2004) 1.10
Thioredoxin superfamily and thioredoxin-inducing agents. Ann N Y Acad Sci (2002) 1.09
Intravenous administration of thioredoxin decreases brain damage following transient focal cerebral ischemia in mice. Antioxid Redox Signal (2004) 1.08
Redox regulation of cell survival by the thioredoxin superfamily: an implication of redox gene therapy in the heart. Antioxid Redox Signal (2009) 1.08
Overexpression of thioredoxin prevents acute hepatitis caused by thioacetamide or lipopolysaccharide in mice. Hepatology (2003) 1.08
Extracellular thioredoxin and thioredoxin-binding protein 2 in control of cancer. Semin Cancer Biol (2006) 1.06
Activation of bone marrow-derived microglia promotes photoreceptor survival in inherited retinal degeneration. Am J Pathol (2008) 1.06
Redox regulation of human thioredoxin network. Antioxid Redox Signal (2006) 1.06
Aberrant expression of selenoproteins in the progression of colorectal cancer. Cancer Lett (2007) 1.05
Thioredoxin-1 ameliorates cigarette smoke-induced lung inflammation and emphysema in mice. J Pharmacol Exp Ther (2008) 1.04
Transgenic expression of antioxidant protein thioredoxin in pancreatic beta cells prevents progression of type 2 diabetes mellitus. Antioxid Redox Signal (2008) 1.04
The role of thioredoxin in the aging process: involvement of oxidative stress. Antioxid Redox Signal (2003) 1.03
Cytoprotective effects of geranylgeranylacetone against retinal photooxidative damage. J Neurosci (2005) 1.03
Immunohistochemical evaluation of oxidative stress markers in chronic hepatitis C. Antioxid Redox Signal (2004) 1.03
Attenuation of retinal photooxidative damage in thioredoxin transgenic mice. Neurosci Lett (2002) 1.02
Thioredoxin as a neurotrophic cofactor and an important regulator of neuroprotection. Mol Neurobiol (2004) 1.02
Comparison of outcomes between patients with alcoholic cirrhosis and those with hepatitis C virus-related cirrhosis. J Gastroenterol Hepatol (2009) 1.02
Redox-active protein thioredoxin-1 administration ameliorates influenza A virus (H1N1)-induced acute lung injury in mice. Crit Care Med (2013) 1.02
Macular ganglion cell layer imaging in preperimetric glaucoma with speckle noise-reduced spectral domain optical coherence tomography. Ophthalmology (2011) 1.01
Cytoprotective effect of thioredoxin against retinal photic injury in mice. Invest Ophthalmol Vis Sci (2002) 1.01
Dendritic cells derived from TBP-2-deficient mice are defective in inducing T cell responses. Eur J Immunol (2008) 0.99